The current shareholding sample launched by Dr Lal PathLabs Ltd on the BSE confirmed that insurance coverage large Life Insurance coverage Company Of India (LIC) has picked up stake within the healthcare firm through the October-December 2021 interval. Shares of Dr Lal PathLabs surged over 1% at ₹3,716.6 apiece on the BSE in Thursday’s early offers.
LIC title has appeared within the December shareholding of Dr Lal PathLabs because it has purchased 1.12% stake or 9,31,246 fairness shares within the firm through the third quarter (Q3) of the present fiscal, BSE knowledge confirmed. The state-owned insurer and funding large didn’t maintain any stake within the agency as of the earlier quarter of July-September 2021 interval.
On the opposite arms, mutual funds (MFs) have elevated their holding within the firm as their stake stands at 3.34% or 27,82,681 shares as of December finish, a rise from 3.26% or 27,17,883 through the second quarter.
Dr Lal PathLabs shares have surged over 55% in a yr’s interval whereas the inventory is up over 6% within the final six months. One in all India’s prime diagnostic chains, the corporate has areas for its diagnostic laboratory companies with over 5000+ diagnostic checks and associated healthcare checks and companies provided.
Supply: Live Mint